[HTML][HTML] Chemotherapy-Induced Alopecia by Docetaxel: Prevalence, Treatment and Prevention

AM Perez, NI Haberland, M Miteva… - Current …, 2024 - mdpi.com
Docetaxel is a commonly used taxane chemotherapeutic agent in the treatment of a variety
of cancers, including breast cancer, ovarian cancer, prostate cancer, non-small cell lung …

Fucoidan treats chemotherapy-induced alopecia and helps cyclophosphamide treat tumors

Z Wang, Y Lai, N Zhang, H Yang, Y Huang… - International Journal of …, 2025 - Elsevier
Chemotherapy-induced alopecia (CIA) represents one of the most common side effects of
cancer treatment. Currently, scalp cooling systems are utilized to treat CIA, but their safety …

Mild oxidative stress protects against chemotherapy-induced hair loss

Y Zhang, JJ Jimenez - Frontiers in Oncology, 2023 - frontiersin.org
Chemotherapy induces hair loss in most cancer patients who undergo treatment, which
causes them significant psychosocial trauma. Scalp cooling has demonstrated some efficacy …

Computational drug discovery in chemotherapy-induced alopecia via text mining and biomedical databases

N Zhang, W Xu, S Wang, Y Qiao, X Zhang - Clinical therapeutics, 2019 - Elsevier
Purpose Chemotherapy-induced alopecia (CIA) is a common and often stressful adverse
effect associated with chemotherapy. CIA can cause more psychosocial pressure in patients …

The role of platelet-rich plasma in the prevention of chemotherapy-induced alopecia

CA Stamatiou, A Lens, CI Perez, S Daunert… - Skin appendage …, 2020 - karger.com
Alopecia is a distressing side effect of chemotherapy. Patients who experience hair loss due
to their chemotherapy treatment have been shown to have decreased social functioning …

[PDF][PDF] The Role of Platelet-Rich Plasma in the Prevention of Chemotherapy-Induced Alopecia

CASAL Carmen, I Perezd, S Daunerta, JJ Jimeneza - 2019 - academia.edu
Group 1 received Ara-C, 25 mg/kg/day ip for 7 days. Group 2 received VP-16, 1.5 mg/kg ip
on days 11–13. Group 3 received Cytoxan (CTX), 37.5 mg/kg ip on day 11. In addition, each …